Nuroden 500 Injection contains Methylcobalamin 500 mcg per ml, a biologically active form of vitamin B12 essential for neurological function and hematopoiesis. It is indicated for the treatment of vitamin B12 deficiency, which may manifest as peripheral neuropathy, megaloblastic anemia, or other neurological disorders related to cobalamin deficiency. Methylcobalamin plays a critical role in the synthesis of myelin and the maintenance of nerve cells, thereby facilitating nerve regeneration and repair. Nuroden 500 Injection is administered intramuscularly or intravenously as prescribed by a healthcare professional, ensuring rapid bioavailability and effective replenishment of cobalamin stores. It is commonly used in conditions such as diabetic neuropathy, alcoholic neuropathy, and other neuropathic pain syndromes where vitamin B12 deficiency is implicated. The injection is also beneficial in the management of pernicious anemia and other malabsorption syndromes. Adverse effects are rare but may include mild injection site reactions or hypersensitivity. Caution is advised in patients with known hypersensitivity to cobalamin or its components. Nuroden 500 Injection should be used under medical supervision with appropriate monitoring of hematological and neurological parameters to assess therapeutic response and guide treatment duration.